#UAE's G42, Sinopharm Seal Production Deal for Millions of Doses - Bloomberg video

UAE's G42, Sinopharm Seal Production Deal for Millions of Doses - Bloomberg

Peng Xiao, CEO of G42 Group, the leading technology company based in Abu Dhabi, discusses the company’s joint venture with China’s Sinopharm CNBG to create the first covid-19 vaccine in the region. The newly formed group plans to produce 200 millon vaccine doses. He speaks with Yousef Gamal El-Din and Manus Cranny on "Bloomberg Daybreak: Middle East." (Source: Bloomberg)